Big pharma outlines deal-making initiatives at ERBI
12 June 2009
Sukaina Virji
Please Login to read the full article.
12 June 2009
Sukaina Virji
sukaina.virji@informa.com
Deal-making has become an important survival strategy for small to medium-sized biotechnology companies in the current credit squeeze, and pharmaceutical companies are keen to take advantage of the early-stage collaborative drug discovery and development opportunities on offer, delegates heard at...
Please Login to read the full article.
RELATED CONTENT
NEWS
- SuperGen and Astex in merger 'almost of equals'
- New GSK spin-out to develop hearing disorder therapies with £10 million funding
- Cancer developer Merrimack dives into a tough IPO pool with a $172M filing
- Harvard University turns to German firm Evotec to add value to diabetes assets
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
